Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
2002 13
2003 10
2004 17
2005 9
2006 17
2007 28
2008 27
2009 38
2010 26
2011 30
2012 36
2013 26
2014 23
2015 48
2016 44
2017 39
2018 38
2019 38
2020 42
2021 36
2022 29
2023 22
2024 21
2025 19

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

595 results

Results by year

Filters applied: . Clear all
Page 1
The combination of body mass index and serum creatinine levels predicts survival in patients with Hodgkin lymphoma treated with nivolumab in the CheckMate 205 study.
De Filippi R, Morabito F, Tripepi G, Ansell SM, Mele S, Morelli E, Mallardo D, Donnarumma D, Volzone F, Akyol A, Cuccaro A, Saggese M, Bonanni M, Esposito M, Crisci S, Zinzani PL, Pinto A. De Filippi R, et al. Among authors: pinto a. Oncoimmunology. 2025 Dec;14(1):2513106. doi: 10.1080/2162402X.2025.2513106. Epub 2025 Jun 1. Oncoimmunology. 2025. PMID: 40452181 Free article.
Prognostic role of interim PET in follicular lymphoma: a post hoc study of FOLL12 trial by Fondazione Italiana Linfomi.
Durmo R, Chauvie S, Fallanca F, Bergesio F, Pinto A, Del Giudice I, Coscia M, Corradini P, Angelucci E, Tosi P, Freilone R, Ballerini F, Bari A, Pastore D, Zinzani PL, Bolis S, Flenghi L, Liso A, Olivieri J, Marcheselli L, Merli M, Versari A, Guerra L, Luminari S. Durmo R, et al. Among authors: pinto a. Blood Adv. 2025 Jun 24;9(12):2927-2934. doi: 10.1182/bloodadvances.2024014790. Blood Adv. 2025. PMID: 40106688 Free article. Clinical Trial.
A Comprehensive Genetic Study of Classical Hodgkin Lymphoma Using Circulating Tumor DNA.
Pirosa MC, Bruscaggin A, Terzi di Bergamo L, Salehi M, Jauk F, Forestieri G, Bocchetta S, Piffaretti D, Moia R, Cristaldi V, di Trani M, Galimberti GA, Pini K, Spina V, Giordano C, Condoluci A, Romano I, Annunziata S, Bergesio F, Boldorini R, Borsatti E, Bulian P, Calabretta E, Chauvie S, Corrado F, Crisci S, Cuzzocrea M, De Filippi R, Gerber B, Kurlapski M, Larocca LM, Merlo E, Rinaldi A, Rodari M, Romanowicz G, Sacchetti GM, Stathis A, Stussi G, Zangrilli I, Pinto A, Mazzucchelli L, Gattei V, Zaucha JM, Santoro A, Hohaus S, Cavalli F, Tzankov A, Carlo-Stella C, Gaidano G, Ceriani L Prof, Zucca E, Rossi D. Pirosa MC, et al. Among authors: pinto a. Blood. 2025 May 13:blood.2024027355. doi: 10.1182/blood.2024027355. Online ahead of print. Blood. 2025. PMID: 40359477
MFRP is a molecular hub that organizes the apical membrane of RPE cells by engaging in interactions with specific proteins and lipids.
Tworak A, Smidak R, Rodrigues Menezes C, Du SW, Suh S, Choi EH, Imanishi SS, Dong Z, Lewandowski D, Fong KE, Grigorean G, Pinto AFM, Xu Q, Skowronska-Krawczyk D, Blackshaw S, Imanishi Y, Palczewski K. Tworak A, et al. Among authors: pinto afm. Proc Natl Acad Sci U S A. 2025 Apr 22;122(16):e2425523122. doi: 10.1073/pnas.2425523122. Epub 2025 Apr 18. Proc Natl Acad Sci U S A. 2025. PMID: 40249779 Free PMC article.
Dietary methionine restriction started late in life promotes healthy aging in a sex-specific manner.
Hernández-Arciga U, Stamenkovic C, Yadav S, Nicoletti C, Albalawy WN, Al Hammood F, Gonzalez TF, Naikwadi MU, Graham A, Smarz C, Little GJ, Williams SG, McMahon B, Sipula IJ, Vandevender AM, Chuan B, Cooke D, Pinto AFM, Flores LC, Hartman HL, Diedrich JK, Brooke RT, Alder JK, Frahm KA, Pascal LE, Stolt E, Troensegaard H, Øvrebø B, Elshorbagy A, Molina E, Vinknes KJ, Tan RJ, Weisz OA, Bueno M, Eickelberg O, Steinhauser ML, Finkel T, Ables GP, Ikeno Y, Olsen T, Sacco A, Jurczak MJ, Sukoff Rizzo SJ, Parkhitko AA. Hernández-Arciga U, et al. Among authors: pinto afm. Sci Adv. 2025 Apr 18;11(16):eads1532. doi: 10.1126/sciadv.ads1532. Epub 2025 Apr 16. Sci Adv. 2025. PMID: 40238871 Free PMC article.
A Cost-Effectiveness Analysis of Mosunetuzumab vs Tisagenlecleucel for Treatment of Third- or Higher-Line (3L+) Relapsed or Refractory (R/R) Follicular Lymphoma (FL) in Italy.
Luminari S, Pinto A, Puccini B, D'Arpino A, Omodeo Salè E, Bellone M, Pradelli L, Sabinot A. Luminari S, et al. Among authors: pinto a. Clinicoecon Outcomes Res. 2025 Apr 16;17:335-348. doi: 10.2147/CEOR.S509907. eCollection 2025. Clinicoecon Outcomes Res. 2025. PMID: 40256614 Free PMC article.
595 results